SaxoCell
Booth: E 01 - E 04
SaxoCell - Living drugs made in Saxony
SaxoCell - Saxony's precision therapy cluster - has set itself the goal of providing effective, safe and affordable cell and gene therapies to patients suffering from serious, untreatable diseases. We combine excellent basic and applied research expertise within Saxony with industrial resources and the know-how of other national and international partners to build a strong network for cell and gene therapy. Our core partners are the Technical University of Dresden, the University of Leipzig and their respective university hospitals, the Fraunhofer Institute for Cell Therapy and Immunology and the Chemnitz Hospital. SaxoCell is a winner of the nationwide Clusters4Future initiative of the BMFTR and is funded with 15 million euros each for the first (2021-2024) and second (2024-2027) implementation phase.
With its current 7 innovative research projects on topics such as CAR-T and (CAR-)NK cell therapies, gene therapies based on designer recombinases and regenerative approaches, SaxoCell is positioned in a broad spectrum of therapy forms that are precisely tailored to the needs of patients. These innovative cell and gene therapies are developed and optimized in Saxony and are to be brought into automated production and ultimately into application with the help of 22 industrial partners and preclinical and clinical studies. In this way, the entire value chain will be mapped in Saxony. In the long term, we want to reduce the costs of such forms of therapy for patients and health insurance companies and strengthen Saxony as a business location.
As an innovative cluster, we are always interested in expanding our network, entering into discussions with new partners and developing project ideas together. We are open to all technologies and see interdisciplinary approaches as a means of advancing cell and gene therapy developments from Saxony in a focused and rapid manner. We pay particular attention to partners in the fields of automation and artificial intelligence.
In addition to actual research and development, we also see ourselves as a support platform in the areas of research transfer, IP and innovation management. The employees from the SaxoCellutions team - SaxoCell's cluster management - with their many years of experience are very well positioned here and are happy to provide advice. We support start-ups with a focus on cell and gene therapy on their way to becoming spin-offs and try to get companies interested in setting up or opening a branch in Saxony. Regional value creation in particular is an important concern in the cluster.